SCHEMBL28973233

SCHEMBL28973233

O=C(O)CN1CCNC[C@@H]1C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.37
SLC6A1 P30531 2/20 0.33
GABRA5 P31644 2/20 0.33
GABRB2 P47870 2/20 0.33
SLC6A12 P48065 2/20 0.33
SLC6A11 P48066 2/20 0.33
SLC6A13 Q9NSD5 2/20 0.33
GABRA1 P14867 1/20 0.33
GABRR1 P24046 1/20 0.33
GABRA4 P48169 1/20 0.33
HTR2A P28223 2/20 0.33
HTR2C P28335 2/20 0.33
MITF O75030 1/20 0.30
HTR2B P41595 1/20 0.30
DDR1 Q08345 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28973118 1.00 GRM2 (0.37) GRM2SLC6A1GABRA5GABRB2SLC6A12
SCHEMBL26637297 1.00 GRM2 (0.37) GRM2SLC6A1GABRA5GABRB2SLC6A12
Trifluoroacetic Acid SCHEMBL28973146 0.95 GRM2 (0.35) GRM2SLC6A1GABRA5GABRB2SLC6A12
SCHEMBL30826013 0.85 GRM2 (0.41) GRM2HTR2AHTR2C
SCHEMBL30826045 0.85 GRM2 (0.41) GRM2HTR2AHTR2C
SCHEMBL7354461 0.83 SLC6A1 (0.33) SLC6A1GABRA5GABRB2SLC6A12SLC6A11
SCHEMBL29170253 0.81 GRM2 (0.35) GRM2HTR2AHTR2CHTR2B
SCHEMBL30403488 0.81 GRM2 (0.35) GRM2HTR2AHTR2CHTR2B
SCHEMBL29170258 0.81 GRM2 (0.35) GRM2HTR2AHTR2CHTR2B
SCHEMBL28212096 0.81 GRM2 (0.33) GRM2HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117715903-A Cereblon binding compounds, compositions thereof, and methods for their use in therapy 新基公司 2024-03-15 CN disclosed
CN-117561249-A Cereblon binding compounds, compositions thereof, and methods for their use in therapy 细胞基因公司 2024-02-13 CN disclosed
CN-115968293-A Cereblon binding compounds, compositions thereof, and methods of use thereof for treatment 新基公司 2023-04-14 CN disclosed
CN-115955979-A Cereblan binding compounds, compositions thereof, and methods for treatment thereof 新基公司 2023-04-11 CN disclosed
CN-115835866-A Cereblon binding compounds, compositions thereof, and methods of use thereof for treatment 新基公司 2023-03-21 CN disclosed